NCT00869791View on ClinicalTrials.gov

A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

IPX066

experimental drug product: extended-release carbidopa-levodopa capsules

DRUG

IR CD-LD

active comparator: immediate-release carbidopa-levodopa capsules

Trial Locations (1)

94544

IMPAX Laboratories, Hayward

Sponsors
All Listed Sponsors
lead

Impax Laboratories, LLC

INDUSTRY

NCT00869791 - A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa | Biotech Hunter | Biotech Hunter